Advertisement

Characterization of Adrenoceptors: Receptor-Binding Studies and Agonist-Antagonist Interaction

  • A. Wellstein
Conference paper

Abstract

In the last decade receptor-binding studies have received ever increasing attention. Especially in adrenergic pharmacology, they have proved to be very powerful and reliable tools in many respects, as outlined in the different articles of the present volume and in the literature [2, 7, 11,12, 17, 20]. However, it must be pointed out that despite such numerous reports, there are still some contradictions and especially confusion about when acceptable proof has been obtained that a radioligand under investigation has indeed bound at receptors [8,20]. In the present paper, we discuss aspects and prerequisites of the receptor binding approach and how this could provide a better understanding of the action of the classical β-adrenoceptor antagonist, propranolol.

Keywords

Hill Slope Equilibrium Dissociation Constant Receptor Binding Study Exercise Tachycardia Spare Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ahlquist RP (1948) A study of ad re not ro pic receptors. Am J Physiol 153: 586–600PubMedGoogle Scholar
  2. 2.
    Brodde OE, Engel G, Hover D, Bcck KD, Weber F (1981) The β -adrcnergic receptor in human lymphocytes: Subclassificationby the use of a new radio-ligand, (+/-) 125-iodocyanopindolol. Life Sci 29: 2189–2198PubMedCrossRefGoogle Scholar
  3. 3.
    Furchgott RF(1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (cds) Catecholamines. Springer, Berlin Heidelberg New York, pp 283-335» Handbook of experimental pharmacology, vol 33Google Scholar
  4. 4.
    Gaddum JH (1957) Theories of drug antagonism. Pharmacol Rev 9: 211–218PubMedGoogle Scholar
  5. 5.
    Gauger D, Kaiser G, Quiring K, Palm D (1975) The β-acrenergic receptor adenyl cyclase-system of rat reticulocytes. Naunyn-Schmiedebergs.Arch Pharmacol 289: 379–389PubMedCrossRefGoogle Scholar
  6. 6.
    Gauss CF (1809) Theoria motus corporum coelestium in sectionibus conicis solern ambientiurn. Lib II, Sect I II, Hamburgi Sumtibus, Fnd Perthes et IH BcsscrGoogle Scholar
  7. 7.
    Gille E, Lemoine H, Ehle B, Kallmann AJ (1985) The affinity of (-)-propranolol for β1- and β2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn-Schmiede bergs Arch Pharmacol 331: 60–70Google Scholar
  8. 8.
    Laduron PM (1984) Criteria for receptor sites in binding studies. Biochem Pharmacol 33: 833–8399. Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967 a) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214: 597–598Google Scholar
  9. 10.
    Lands AM, Luduena FP, Buzzo HJ (1967 b) Differentiation of receptors responsive to isoproterenol. Life Sci 6: 2241–2249Google Scholar
  10. 11.
    Lefkowitz RJ, Stadel JM, Caron MG (1983) Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. Annu Rev Biochem 52: 159–186PubMedCrossRefGoogle Scholar
  11. 12.
    Motulsky HJ, Insel PA (1982) Adrenergic receptors in man. Direct identification, physiologic regulation, and clinical alterations. N Engl J Med 307: 18–29Google Scholar
  12. 13.
    Palm D, Wellstein A (1985) Multipotente Arzneistoffe - Hybride und Pseudohybride. In: Holzgreve H (ed) Kombinierte Alpha- und Beta-Adrenozeptorenblockade mit symbiontischen Molekülen. Ein neues Therapiekonzept bei Hypertonie und koronarer Herzkrankheit. MMW Medizin Verlag, München, pp 28–56Google Scholar
  13. 14.
    Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–672CrossRefGoogle Scholar
  14. 15.
    Staehelin M, Simons P, Jaeggi K, Wigger N (1983) CGP12177. A hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 258: 3496–3502PubMedGoogle Scholar
  15. 16.
    Von Hattingberg HM, Brockmeier D, Kreuter G (1977) A rotating iterative procedure ( RIP) for estimating hybrid constants. Eur J Clin Pharmacol 11: 381–388Google Scholar
  16. 17.
    Wellstein A, Palm D, Wiemer G, Schäfer-Körting M, Mutschier E (1984) Simple and reliable radioreceptor assay for β-adrenoceptor antagonists and active metabolites in native human plasma. Eur J Clin Pharmacol 27: 545–553PubMedCrossRefGoogle Scholar
  17. 18.
    Wellstein A, Palm D, Beiz GG, Pitschner HF (1985) Receptor binding of propranolol is the missing link between plasma concentration kinetics and effect time course in man. Eur J Clin Pharmacol 29: 131–147PubMedCrossRefGoogle Scholar
  18. 19.
    Wiemer G, Wellstein A, Palm D, von Hattingberg HM, Brockmeier D (1982) Properties of agonist binding at the β-adrenoceptor of the rat reticulocyte. Naunyn-Schmiedebergs Arch Pharmacol 321: 11–19PubMedCrossRefGoogle Scholar
  19. 20.
    Williams LT, Lefkowitz RJ (1978) Receptor binding in adrenergic pharmacology. Raven, New YorkGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • A. Wellstein
    • 1
  1. 1.Zentrum der PharmakologieKlinikum der J. W. Goethe-UniversitätFrankfurt 70Federal Republic of Germany

Personalised recommendations